UK small-cap RNS · 3 Nov 2025
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
21:15
Diversified Energy Achieves Strong Quarterly Results and Raises 2025 Financial Guidance ResultsRaises 2025 Adjusted EBITDA guidance to $900-925m from $825-875m and Adjusted FCF to ~$440m from ~$420m, citing synergy capture, portfolio optimisation and a strong third quarter.ahead of expectationsoutlook positive, raisedfirst since Oct 2023 +8.4% on the dayMoved: new: Canvas Energy acquisition – Agreed; on track to close 4Q 2025 · new: US redomestication and NYSE listing – Proposed redomestication
-
18:08
Wildcat Petroleum WCAT £2.4mUpdate on Publishing the Annual Financial Results ResultsWildcat Petroleum Plc ("WCAT") a company targeting investment opportunities in businesses and assets within the upstream sector of the petroleum industry refers to its announcement at 7:00 a.m and 8:07 a.m today (RNS Number: 8611F and 8738F) regarding the …+0.0% on the day
-
08:07
Wildcat Petroleum WCAT £2.4mUpdate on publishing Annual Financial Results ResultsWildcat Petroleum Plc ("WCAT") a company targeting investment opportunities in businesses and assets within the upstream sector of the petroleum industry refers to its announcement at 7am today (RNS Number: 8611F) regarding the publication of the Annual …+0.0% on the dayMoved: new: Trading suspension over results publication – Suspension requested; technical upload failure
-
08:00
Update on publication of Annual Report & Accounts ResultsTechnology Minerals Plc (LSE: TM1), the first listed UK company focused on creating a sustainable circular economy for battery metals, announces that the publication of its annual report and accounts for the year ended 30 June 2025 (the "Accounts"), which …+0.0% on the day
-
07:54
Critical Metals CRTM £83mDelay to the Publication of Final Results ResultsCritical Metals plc / EPIC: CRTM / Market: Main Market+0.0% on the day
-
07:00
Kosmos Energy KOS £1,224m3rd Quarter Results ResultsQ3 swung to a $124m net loss (adjusted loss $72m) from a $45m profit a year earlier, hit by a $51.1m Winterfell-4 write-off and higher financing costs, though production and costs improved.Moved: new: 2026 and 2027 debt maturities – $150m of 2026 notes redeemed; $100m left · new: GTA Phase 1 ramp-up – Ramping up; nameplate targeted end Q4 2025 · new: Ghana licence extension to 2040 – Documents prepared for submission
-
07:00
Renalytix RENX £40mAudited Full Year Fiscal 2025 Results ResultsRevenue up 30% to $3.0m, gross margin rose to 40% from 9% and administrative costs fell to $18.4m from $30.7m, though the business is still small and loss-making.outlook positivefirst since Oct 2023 −10.5% on the dayMoved: new: Strategic partnerships and EMR rollout – Tempus AI and MVP agreements signed; more expected
-
07:00
Final Results ResultsDelivered on Target and Scaling the Company for the Futurefirst since Oct 2023 +5.0% on the day